Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024

Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System — Oct 18th, 2024

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Foo...

Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024

Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System — Oct 18th, 2024

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Foo...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System — Oct 18th, 2024

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Foo...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Boston Scientific (BSX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates — Oct 18th, 2024

The upcoming report from Boston Scientific (BSX) is expected to reveal quarterly earnings of $0.58 per share, indicating an increase of 16% compared to the year-ago period. Analysts forecast revenues of $4.03 billion, representing an increase of 14.4% year over year. Over the past 30 days...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System — Oct 18th, 2024

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Foo...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System — Oct 18th, 2024

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Foo...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Boston Scientific (BSX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates — Oct 18th, 2024

The upcoming report from Boston Scientific (BSX) is expected to reveal quarterly earnings of $0.58 per share, indicating an increase of 16% compared to the year-ago period. Analysts forecast revenues of $4.03 billion, representing an increase of 14.4% year over year. Over the past 30 days...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific (BSX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates — Oct 18th, 2024

The upcoming report from Boston Scientific (BSX) is expected to reveal quarterly earnings of $0.58 per share, indicating an increase of 16% compared to the year-ago period. Analysts forecast revenues of $4.03 billion, representing an increase of 14.4% year over year. Over the past 30 days...

Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System — Oct 18th, 2024

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Foo...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Boston Scientific (BSX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates — Oct 18th, 2024

The upcoming report from Boston Scientific (BSX) is expected to reveal quarterly earnings of $0.58 per share, indicating an increase of 16% compared to the year-ago period. Analysts forecast revenues of $4.03 billion, representing an increase of 14.4% year over year. Over the past 30 days...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...

Boston Scientific launches next-gen cardiac mapping for FARAPULSE — Oct 19th, 2024

https://www.tipranks.com/news/the-fly/boston-scientific-launches-next-gen-cardiac-mapping-for-farapulse Boston Scientific (BSX) Corporation announced it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of p...

Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024

Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement — Oct 21st, 2024

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a c...